Free Trial
NASDAQ:ATPC

Agape ATP (ATPC) Stock Price, News & Analysis

Agape ATP logo
$1.08 +0.01 (+0.93%)
Closing price 03/11/2025 04:00 PM Eastern
Extended Trading
$1.05 -0.03 (-2.78%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Agape ATP Stock (NASDAQ:ATPC)

Key Stats

Today's Range
$1.02
$1.11
50-Day Range
$0.92
$1.97
52-Week Range
$0.90
$8.40
Volume
68,137 shs
Average Volume
1.55 million shs
Market Capitalization
$4.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Remove Ads

Agape ATP Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

ATPC MarketRank™: 

Agape ATP scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Agape ATP.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Agape ATP is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Agape ATP is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Agape ATP has a P/B Ratio of 0.95. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Agape ATP's valuation and earnings.
  • Percentage of Shares Shorted

    5.81% of the float of Agape ATP has been sold short.
  • Short Interest Ratio / Days to Cover

    Agape ATP has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Agape ATP has recently decreased by 5.69%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Agape ATP does not currently pay a dividend.

  • Dividend Growth

    Agape ATP does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.81% of the float of Agape ATP has been sold short.
  • Short Interest Ratio / Days to Cover

    Agape ATP has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Agape ATP has recently decreased by 5.69%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Agape ATP has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Agape ATP this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Agape ATP insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.67% of the stock of Agape ATP is held by insiders.

  • Percentage Held by Institutions

    Only 0.01% of the stock of Agape ATP is held by institutions.

  • Read more about Agape ATP's insider trading history.
Receive ATPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agape ATP and its competitors with MarketBeat's FREE daily newsletter.

ATPC Stock News Headlines

Agape ATP prices 46M shares at 50c in private placement
Former CIA to Trump – Will you Shut down this secret lab?
Deep in the sands of New Mexico lies a government lab so secret it makes Area 51 look like a tourist spot… The scientists here aren’t toying with viruses or weather manipulation technology… No, they’re into something far more alien…
Agape ATP Corp Increases Authorized Shares
CI_HSI RC2611C (67179.HK)
Why Is Agape ATP Stock Jumping Today?
See More Headlines

ATPC Stock Analysis - Frequently Asked Questions

Agape ATP's stock was trading at $1.18 at the beginning of 2025. Since then, ATPC stock has decreased by 8.5% and is now trading at $1.08.
View the best growth stocks for 2025 here
.

Shares of Agape ATP reverse split on Friday, August 30th 2024. The 1-20 reverse split was announced on Wednesday, August 28th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Agape ATP (ATPC) raised $7 million in an IPO on Wednesday, October 11th 2023. The company issued 1,700,000 shares at $4.00 per share. Network 1 Financial Securities served as the underwriter for the IPO.

Shares of ATPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agape ATP investors own include Canoo (GOEV), NVIDIA (NVDA), Plug Power (PLUG), Advanced Micro Devices (AMD), iShares Core S&P 500 ETF (IVV), Mustang Bio (MBIO) and Meta Platforms (META).

Company Calendar

Today
3/11/2025
Next Earnings (Estimated)
4/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Health services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:ATPC
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-2,100,000.00
Net Margins
-194.09%
Pretax Margin
-192.76%

Debt

Sales & Book Value

Annual Sales
$1.35 million
Price / Cash Flow
N/A
Book Value
$1.14 per share
Price / Book
0.95

Miscellaneous

Free Float
3,604,000
Market Cap
$4.31 million
Optionable
Not Optionable
Beta
2.31
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ATPC) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners